RITUXIMAB-RESISTANT CHIMERIC ANTIGEN RECEPTORS AND USES THEREOF

Provided herein are polynucleotides encoding chimeric antigen receptors (CARs) comprising a CD 19 antigen binding domain that specifically binds to CD 19 and is resistant to rituximab binding; and immune cells comprising these CD19-specific CARs, e.g., CAR-T cells. Also provided are methods of makin...

Full description

Saved in:
Bibliographic Details
Main Authors PERTEL, Thomas Charles, SASU, Barbra Johnson, LEONARD, Mark W
Format Patent
LanguageEnglish
French
German
Published 27.12.2023
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online AccessGet full text

Cover

More Information
Summary:Provided herein are polynucleotides encoding chimeric antigen receptors (CARs) comprising a CD 19 antigen binding domain that specifically binds to CD 19 and is resistant to rituximab binding; and immune cells comprising these CD19-specific CARs, e.g., CAR-T cells. Also provided are methods of making and using these CD 19-specific CARs, and immune cells comprising these CD19-specific CARs.
Bibliography:Application Number: EP20230186544